ICU Medical, Inc.
ICUI
Positions held
Your positionsICUI isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- ICU Medical operates in the growing medical instruments and supplies industry, which is driven by increasing healthcare demands and advancements in technology.
- Revenue increased by 4% compared to the prior quarter, reaching $552 million.
- Gross margin improved to 42.6%, up from 38.9% in the previous quarter.
- The company's earnings growth has been negative, with a decline of 46.9% recently, indicating potential challenges in profitability.
- Net income for the most recent quarter was $19.1 million, a decrease from $30.1 million in the previous quarter.
- The trailing P/E ratio is high at 134.23, suggesting the stock may be overvalued compared to its earnings.
Fundamentals
| Market cap | $3.93B | Enterprise value | $4.92B | Trailing P/E | 132.08 | Forward P/E | 16.29 |
| PEG | 0.08 | Price / book | 1.83 | Beta | 0.87 | Dividend yield | 0.00% |
| Revenue growth | 0.5% | Earnings growth | -46.9% | Gross margin | 38.3% | Operating margin | 7.5% |
| Profit margin | 1.4% | ROE | 1.4% | ROA | 1.9% | Debt / equity | 0.60 |
| Current ratio | 2.43 | Free cash flow | $163.56M | Analyst recommendation | none | Mean target | $193.38 |
| 52w high | $192.85 | 52w low | $112.50 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $552M | $530M | $541M | $537M | $549M |
| Op margin | 11.0% | 5.7% | 4.8% | 5.0% | 4.9% |
| Net income | $19.1M | $30.1M | -$15.7M | -$3.4M | $35.3M |
| Gross margin | 42.6% | 38.9% | 37.5% | 37.4% | 37.9% |
| Gross profit | $235M | $206M | $203M | $201M | $208M |
| Operating income | $60.4M | $30.4M | $26.1M | $26.9M | $26.8M |
- Revenue +4% vs prior quarter ($552M vs $530M).
- Gross margin 42.6% (was 38.9% prior quarter).
- Operating margin expanded to 11%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.4B | $2.3B | $2.3B | — |
| Op margin | 4.9% | 4.1% | 2.1% | -0.2% | — |
| Net income | $0.7M | -$118M | -$29.7M | -$74.3M | — |
| Gross margin | 36.8% | 34.6% | 32.8% | 30.6% | — |
| Gross profit | $822M | $825M | $740M | $698M | — |
| Operating income | $109M | $97.4M | $47.8M | -$3.6M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · Is ICU Medical (ICUI) Undervalued After Two FDA Class II Recalls?
2026-09-28 · 2 Volatile Stocks to Target This Week and 1 We Turn Down
2026-09-19 · ICU Medical (ICUI) Stock May Be 26% Undervalued On Cash Flow
2026-09-18 · Vascular Access Device Market by Type, Route of Insertion, Application, End User - Global Forecast to 2031
2026-09-17 · ICU Medical CFO Sells 6,381 Shares for $1.1 Million
2026-09-17 · ICU Medical CFO Brian Bonnell Sells 9,307 Shares
2026-09-07 · BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure
2026-09-01 · ICU Medical Insider Sold Shares Worth $1,116,675, According to a Recent SEC Filing
2026-08-31 · ICU Medical Insider Sold Shares Worth $1,608,143, According to a Recent SEC Filing
2026-08-27 · ICU Medical to Participate in Upcoming Investor Conferences
Price (daily)
Full chart · RSI · MACD · patterns